Merck and Ridgeback Bio Collaborate to Advance Development of Novel Antiviral Candidate, EIDD-2801 Read more
Repare Therapeutics Announces Multi-Target Discovery Collaboration with Bristol Myers Squibb Read more
FDA Approves Dupixent (dupilumab) for Children Aged 6 to 11 Years with Moderate-to-Severe Atopic Dermatitis Read more
Tavotek Announces a Research Agreement with Genmab for the Development of Bispecific Antibodies Read more